Main competitors
| Add to a list | Consensus
| 4m Target Price Revision
| 4m Revision of opinion
| Divergence of analysts' opinions
| Divergence of Target Price
| Average Target P.
| Ecart obj. / dr
| Nbr of analysts
|
---|
| | | | | | |
¥9,486.36
| +29.51% | 11 |
| | | | | | |
₹2,076.97
| +22.14% | 37 |
| | | | | | |
CHF 49.36
| -0.56% | 15 |
| | | | | | |
₹1,644.19
| +12.66% | 37 |
| | | | | | |
₹1,069.68
| +18.61% | 31 |
| | | | | | |
€150.62
| -8.16% | 6 |
| | | | | | |
HUF 12,221.56
| +13.69% | 9 |
| | | | | | |
¥1,943.85
| +27.84% | 13 |
| | | | | | |
CN¥40.09
| +37.91% | 3 |
| | | | | | |
₹1,741.46
| +31.62% | 13 |
| | | | | | |
ZAR 212.2
| +23.73% | 5 |
| | | | |
-
| |
SAR 181.15
| -5.65% | 2 |
| | | | | | |
₹3,029.9
| +18.34% | 10 |
| | | | | | |
SAR 176.9
| +10.15% | 5 |
| | | | | | |
₩360,933.33
| +38.55% | 15 |
| | | | | | |
HK$8.461
| +29.73% | 5 |
|
Average
| | | | | |
24,685.38
|
+18.76%
|
14
|
|
Weighted average by Cap.
| | | | | |
8,014.98
|
+18.21%
|
22
|
Generic Pharmaceuticals